| Code | 0751F | ||||||||||
| MA number | EU/1/25/1931/002 | ||||||||||
| Product Form: | plc ifc 2x300 mg (liek.inj.skl.) | ||||||||||
| MA Status: | Ex - Conditional centralised marketing authorisation | ||||||||||
| Type of procedure: | EU Orphan | ||||||||||
| MAH, country: | Jazz Pharmaceuticals Ireland Ltd, Ireland | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 27.06.2025 |
| Validity: | 27.06.2026 |
| Safety feature | Yes |
| Data update: | 27.07.2025 |
